The founder and former CEO of Turing Pharmaceuticals, Martin Shkreli, invoked his Fifth Amendment right against compelled self-incrimination on Wednesday, and he won’t comply with a subpoena for documents issued from a Senate panel investigating pharma drug pricing tactics.
The 32-year-old Shkreli was also subpoenaed to appear before a different panel, the US House Committee on Oversight and Government Reform, to testify about the price of a life-saving drug he increased by more than 5,000 percent.
Shkreli became the poster child for greed last year after he raised the price of Daraprim—used to treat parasitic infections—from $13.50 a pill to $750. A single pill once sold for $1. Now facing criminal charges that he allegedly defrauded investors, Shkreli has said he should have boosted prices for the drug even more.
Read 5 remaining paragraphs | Comments